Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Lensar Files for Chapter 11 Bankruptcy Protection

BioPhotonics
Mar 2017
ORLANDO, Fla., Jan 6, 2017 — Lensar, an Orlando-based developer of surgical ultrafast laser systems for cataract treatment, has filed for Chapter 11 bankruptcy protection.

The company was acquired a year ago by social commerce business, Alphaeon, in a debt, cash and stock deal valued at around $59 million.

Coupled with a restructuring, the bankruptcy filing will allow Lensar to cut its debt levels. PDL Biopharma, its senior secured creditor, supports the decision.

With financial support from PDL, Lensar intends to continue to pay all employee obligations, including employee wages, provide health care and other benefits, and all current operating expenses without interruption.

With the Chapter 11 case expected to conclude in the second quarter of 2017, a Lensar representative said the company will continue working with its vendors, suppliers and partners as normal during and after the bankruptcy process.

Lensar is one of a handful of heavily financed companies targeting what is expected to become a huge market for ultrashort-pulsed laser procedures in cataract surgery as the global population ages.


Lensarpulsed lasersultrafast lasersBusinessbiophotonicslasersAlphaeonPDL Biopharmacataract surgeryRapidScan

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2017 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!